ExLibris header image
SFX Logo
Title: Survival of Escherichia coli host-vector systems in the mammalian intestine
Source:

Science [0036-8075] Levy, S B yr:1980


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Siegler, R. "Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome." JAMA 290.10 (2003): 1379-1381. Link to SFX for this item
2. Bovee-Oudenhoven, Ingeborg M J M. "Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium." Gastroenterology 125.2 (2003): 469-76. Link to SFX for this item
3. Farstad, H. "Cerebral venous thrombosis and Escherichia coli infection in neonates." Acta pædiatrica 92.2 (2003): 254-7. Link to Full Text for this item Link to SFX for this item
4. Decludt, B. "Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France." Epidemiology and infection 124.2 (2000): 215-220. Link to Full Text for this item Link to SFX for this item
5. Bovee-Oudenhoven, I M M. "Dietary calcium inhibits the intestinal colonization and translocation of Salmonella in rats." Gastroenterology 113.2 (1997): 550-7. Link to SFX for this item
6. Bell, B P P. "Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157: H7 infections." Pediatrics 100.1 (1997). Link to SFX for this item
7. Laine, P P J. "Intracranial vascular abnormalities: value of MR phase imaging to distinguish thrombus from flowing blood." AJR, American journal of roentgenology 156.2 (1991): 373-80. Link to SFX for this item
8. Kayed, Nanna S S. "Preterm infants' timing strategies to optical collisions." Early Human Development 84.13 (2007): 381-8. Link to SFX for this item
9. Razzaq, S. "Hemolytic uremic syndrome: An emerging health risk." American family physician 74.6 (2006): 991-996. Link to SFX for this item
10. Dundas, S. "The central Scotland Escherichia coli O157 : H7 outbreak: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients." Clinical infectious diseases 33.7 (2001): 923-931. Link to SFX for this item
11. Bradley, W G G. "Carmen lecture. Flow phenomena in MR imaging." AJR, American journal of roentgenology 150.5 (1988): 983-994. Link to SFX for this item
12. Proulx, F. "Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis." The journal of pediatrics 121.2 (1992): 299-303. Link to Full Text for this item Link to SFX for this item
13. Gupta, L K. "Differentiation of calcification from chronic hemorrhage with corrected gradient echo phase imaging." Journal of computer assisted tomography 25.5 (2001): 698-704. Link to SFX for this item
14. Taylor, J. The lancet 363.7600 (2004): 1941-895. Link to SFX for this item
15. Ake, Julie A A. "Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion." Pediatrics 115.6: -80. Link to SFX for this item
16. Cowan, F. "Magnetic resonance imaging in perinatal brain injury: clinical presentation, lesions and outcome." Pediatric radiology 36.7 (2006): 582-592. Link to SFX for this item
17. Trachtman, H. "Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial." JAMA 290.10 (2003): 1337-44. Link to SFX for this item
18. Pallen, Toru A. "An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination." Proceedings of the National Academy of Sciences of the United States of America 103.40 (2006): 14941-6. Link to Full Text for this item Link to SFX for this item
19. Tarr, Wayne L L. "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome." The lancet 365.9464 (2005): 1073-86. Link to SFX for this item
20. Schmidt, B. "Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial." Biology of the neonate 88.3 (2005): 208-13. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.